Skip to main content
Content for healthcare professionals only
Radcliffe Group
Cardiology
Vascular
Medical Education
Register for FREE
Log In
View all Platforms
Cardiology
Topics
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
Events
Upcoming Events
Radcliffe Events
All Events
Radcliffe Platforms
Radcliffe Group
Cardiology
Vascular
Medical Education
Register for FREE
Log In
Content for healthcare professionals only
Topics
Featured
Advancement in Heart Failure
Amyloidosis
Cardiomyopathy
Cardio-oncology
Diabetes
Hypertension Management
Nonalcoholic Steatohepatitis (NASH)
Obesity
Pulmonary Embolism
Stroke Prevention in Atrial Fibrillation
Sudden Cardiac Death
Anticoagulation
COVID-19
CV Disease in Special Populations
Demographic
Digital Health
Electrophysiology & Arrhythmia
Heart Failure
Heterogeneous Populations
Imaging & Diagnostics
Intervention
MI / ACS
Pericardium Disorders
Prevention & Chronic Conditions
Standards & Guidelines
Vascular Disease & Surgery
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
View All
Juan Carlos Kaski
Peter O'Kane
Ankur Kalra
Angelo Auricchio
Harriette Van Spall
Andrew Coats
Mirvat Alasnag
Arjun Ghosh
Demos Katritsis
Nicolas Van Mieghem
Joost Daemen
Carolyn Lam
Events
Upcoming Events
Radcliffe Events
All Events
Breadcrumb
Home /
News Index
Latest News
Written by:
Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
Increased Physical Activity Linked to Reduced Heart Failure Risk in Older Women
01 March 2024
Written by:
Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
Treatment Effect of NOAC Vs Wafarin in AF Shows Generally Consistent Stroke Rates Across the Spectrum of BMI…
29 February 2024
Written by:
EHRA 2024
European Heart Rhythm Association (EHRA) Congress 2024 Reveals its Late-Breaking Clinical Trial…
26 February 2024
Written by:
THT 2024
Technology and Heart Failure Therapeutics (THT) Conference Unveils its Late-Breaking Clinical Trial…
26 February 2024
Written by:
PAD Pulse Alliance
New Data: 70% of Americans Unaware of Common Vascular Disease That is One of the Leading Causes of…
19 February 2024
Written by:
Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
Long-Term Survival Benefit Associated with CRT-D Compared to ICD in HF in the RAFT Trial
09 February 2024
Written by:
Radcliffe Cardiology, Greg Guillory
New Study Finds Lipoprotein(a) More Atherogenic Compared to LDL
06 February 2024
Written by:
ACC.24, Radcliffe Cardiology
American College of Cardiology Reveals its Late-Breaking Clinical Trial Presentations for 2024
30 January 2024
Written by:
Radcliffe Cardiology, Mirjam Boros; Special Editor: Greg Guillory
Apixaban Reduces Stroke Risk in Subclinical Atrial Fibrillation Compared to Aspirin at the Cost of Increased…
19 January 2024
Written by:
Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
Encouraging Top Line Results from ARISE-HF Phase III Study of AT-001 in Diabetic Cardiomyopathy
19 January 2024
Load More
External news
Written by:
Cardiovascular Business
Intermittent fasting may increase risk of death from heart attack, stroke
18 March 2024
Written by:
Cardiovascular Business
Doctors form new coalition focused on reducing private equity’s role in cardiology, other healthcare specialties
18 March 2024
Written by:
Cardiovascular Business
Incidental breast calcifications on mammograms linked to much higher risk of cardiovascular disease
18 March 2024
Written by:
Cardiovascular Business
FDA grants new resorbable scaffold for CLTI its breakthrough device designation
18 March 2024
Written by:
Cardiac Vascular News
Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
18 March 2024
Written by:
heart.org - Heart news
8-hour time-restricted eating linked to a 91% higher risk of cardiovascular death
18 March 2024
Written by:
Cardiac Vascular News
Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
18 March 2024
Written by:
Cardiac Vascular News
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
18 March 2024
Written by:
Cardiac Vascular News
Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System
18 March 2024
Written by:
Cardiac Vascular News
Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy
18 March 2024
Load More